Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

AIM WINNERS & LOSERS: OptiBiotix and Ixico rise on deal wins

Mon, 17th Nov 2025 10:58

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

----------

AIM - WINNERS

----------

OptiBiotix Health PLC, up 7.4% at 8.32 pence, 12-month range 7.50p-23.50p. The life sciences firm has won a deal with a "well-known weight management company". OptiBiotix, which makes products aimed at reducing food cravings, says the deal is in the low six-figures.

----------

Ixico PLC, up 7.0% at 11.50p, 12-month range 7.35p-15.00p. The medical research company has won a contract with a global pharmaceutical company to provide imaging services for a phase 3 trial in Huntington's Disease. The deal is worth GBP3.5 million over four years.

----------

AIM - LOSERS

----------

Polar Capital Holdings PLC, down 4.0% at 526.00p, 12-month range 340.50p-590.00p. The fund manager reports a rise in assets under management but notes "the macro environment is uncertain and likely to remain volatile". Assets under management at September 30 were up 25% at GBP26.7 billion at the September 30 half-year end, from GBP21.4 billion in March. Net outflows during the period, however, total GBP690 million, compared to inflows of GBP472 million a year prior. The AuM increase, which took it to an all-time high, stemmed from a GBP6.3 billion boost from investment performance and market movement, Polar Capital says.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

OptiBiotix Health Ixico Polar Capital

Shares in this article

Related News

TRADING UPDATES: BTG to beat expectations; Sabre backs outlook
1 day ago

TRADING UPDATES: BTG to beat expectations; Sabre backs outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Corporate News Niox Group + 8 more shares
IN BRIEF: Ixico reaffirms growth guidance as half-year revenue rises
3 days ago

IN BRIEF: Ixico reaffirms growth guidance as half-year revenue rises

Ixico PLC - London-based medical research company, focused on analysing trial data using neuroscience imaging and biomarkers - Reports results for the...

Ixico reports higher interim revenue, larger order book
3 days ago

Ixico reports higher interim revenue, larger order book

(Sharecast News) - Ixico reported higher interim revenue and a larger order book on Tuesday, as new contract wins, extensions and increased biomarker ...